# CARsgen Therapeutics Corporation – FDA Inspection, Sep 6, 2024

Source: https://www.keypedia.com/records/fda_inspections/carsgen-therapeutics-corporation/f253bef8-e305-4959-88b3-fa4fcf1c7505
Source feed: FDA_Inspections

> FDA inspection 1252129 of CARsgen Therapeutics Corporation, September 06, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252129
- Company Name: CARsgen Therapeutics Corporation
- Inspection Date: 2024-09-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Officers

- [Alan L. Truong](https://www.keypedia.com/people/alan-l-truong/8b9c59ed-ce68-44c3-9fbe-07cc3da13713)
- [FDA Associated Person](https://www.keypedia.com/people/travis-s-bradley/4d7756cb-65fd-4bd6-be24-25710668e6d8)

Company: https://www.keypedia.com/companies/carsgen-therapeutics-corporation/1cb150da-31e2-4668-88ee-2d9b7f8d5374

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d